Veterinary Experimental and Diagnostic Pathology is a rapidly evolving field that has seen significant advancements in recent years. The discipline focuses on understanding the mechanisms of diseases in animals, developing diagnostic tools, and improving therapeutic strategies. Despite the progress, there remain critical gaps in our knowledge, particularly in the areas of disease pathogenesis, diagnostic accuracy, and treatment efficacy. Recent studies have highlighted the importance of molecular techniques and advanced imaging in diagnosing and understanding animal diseases. However, there is still a need for more comprehensive research to address the complexities of emerging diseases, zoonotic threats, and the development of resistance to current treatments. This research topic aims to provide a comprehensive overview of the latest advancements and future challenges in Veterinary Experimental and Diagnostic Pathology. The primary objectives include identifying the most pressing questions in the field, testing new hypotheses, and exploring innovative diagnostic and therapeutic approaches. By addressing these aims, the research topic seeks to inspire and guide future research efforts, ultimately improving animal health and welfare. To gather further insights in the field of Veterinary Experimental and Diagnostic Pathology, we welcome articles addressing, but not limited to, the following themes:- Advances in molecular diagnostics and imaging techniques Imaging techniques is suggestive of X-ray, MRI and CT. Those techniques pertain to a different specialty and I don’t think those type of papers align with our journal.- Pathogenesis of emerging and re-emerging animal diseases- Development and validation of novel therapeutic strategies- Zoonotic diseases and their impact on public health- Resistance mechanisms to current treatments and preventive measures- Comparative pathology and its implications for human and animal health- Innovations in veterinary pathology education and training- Analytical and diagnostic validation of new biomarkers
Veterinary Experimental and Diagnostic Pathology is a rapidly evolving field that has seen significant advancements in recent years. The discipline focuses on understanding the mechanisms of diseases in animals, developing diagnostic tools, and improving therapeutic strategies. Despite the progress, there remain critical gaps in our knowledge, particularly in the areas of disease pathogenesis, diagnostic accuracy, and treatment efficacy. Recent studies have highlighted the importance of molecular techniques and advanced imaging in diagnosing and understanding animal diseases. However, there is still a need for more comprehensive research to address the complexities of emerging diseases, zoonotic threats, and the development of resistance to current treatments. This research topic aims to provide a comprehensive overview of the latest advancements and future challenges in Veterinary Experimental and Diagnostic Pathology. The primary objectives include identifying the most pressing questions in the field, testing new hypotheses, and exploring innovative diagnostic and therapeutic approaches. By addressing these aims, the research topic seeks to inspire and guide future research efforts, ultimately improving animal health and welfare. To gather further insights in the field of Veterinary Experimental and Diagnostic Pathology, we welcome articles addressing, but not limited to, the following themes:- Advances in molecular diagnostics and imaging techniques Imaging techniques is suggestive of X-ray, MRI and CT. Those techniques pertain to a different specialty and I don’t think those type of papers align with our journal.- Pathogenesis of emerging and re-emerging animal diseases- Development and validation of novel therapeutic strategies- Zoonotic diseases and their impact on public health- Resistance mechanisms to current treatments and preventive measures- Comparative pathology and its implications for human and animal health- Innovations in veterinary pathology education and training- Analytical and diagnostic validation of new biomarkers